GTR Home > Tests > Search results - C0686353[DISCUI]

Apply filters

Showing tests for all 328 conditions

Compare labs

  • Hide states

GTR test search results for C0686353[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 23 tests for 328 conditions in 6 labs

CLimb-girdle muscular dystrophy, autosomal recessice type 2F

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CLimb-girdle muscular dystrophy, autosomal recessive type 2B

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CLimb-girdle muscular dystrophy, autosomal recessive type 2C

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CLimb-girdle muscular dystrophy, autosomal recessive type 2E

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CLimb-girdle muscular dystrophy, autosomal recessive type 2H

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CLimb-girdle muscular dystrophy, autosomal recessive type 2I

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CLimb-girdle muscular dystrophy, autosomal recessive type 2K

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CLimb-girdle muscular dystrophy panel

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total targets (21)

CAshkenazi Jewish Carrier Screen: Gene Sequencing Panel

Test targets
Methods
  • X Mutation scanning of select exons
  • C Sequence analysis of the entire coding region
Total conditions (20)
Total targets (20)

CPan-Ethnic Carrier Screen: Gene Sequencing Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
Total conditions (136)
Total targets (147)

CLimb-Girdle Muscular Dystrophies Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Total conditions (28)
Total targets (26)

CCardiomyopathy and Arrhythmia Panel, Sequencing (85 Genes) and Deletion/Duplication (83 Genes)

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (153)
Total targets (85)

CCardiomyopathy and Arrhythmia Deletion/Duplication, 83 Genes

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Total conditions (151)
Total targets (83)

CCardiomyopathy and Arrhythmia Panel, Sequencing, 85 Genes

Lab: ARUP Laboratories, Molecular Genetics Salt Lake City, Utah, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (153)
Total targets (85)

CSGCD

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CSGCA

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CSGCB

Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Showing 1 to 20 of 23 tests for 328 conditions in 6 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.